{"sourcedb":"DevicePMAs@therightstef","sourceid":"P170002_S000","text":"Approval for the RH-2.  The RHA 2 is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older. RHA 3 is indicated for injection into the mid-to-deep dermis for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older. RHA 4 is indicated for injection into the deep dermis to superficial subcutaneous tissue for the correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLF), in adults aged 22 years or older.","project":"consensus_PMA_Age_Indications","denotations":[{"id":"T18","span":{"begin":658,"end":663},"obj":"age_end"},{"id":"T17","span":{"begin":649,"end":654},"obj":"age_start_unit"},{"id":"T6","span":{"begin":646,"end":663},"obj":"age_range"},{"id":"T16","span":{"begin":646,"end":648},"obj":"age_start"},{"id":"T9","span":{"begin":634,"end":640},"obj":"age_category"},{"id":"T15","span":{"begin":427,"end":432},"obj":"age_end"},{"id":"T14","span":{"begin":418,"end":423},"obj":"age_start_unit"},{"id":"T4","span":{"begin":415,"end":432},"obj":"age_range"},{"id":"T13","span":{"begin":415,"end":417},"obj":"age_start"},{"id":"T8","span":{"begin":403,"end":409},"obj":"age_category"},{"id":"T10","span":{"begin":224,"end":229},"obj":"age_end"},{"id":"T12","span":{"begin":215,"end":220},"obj":"age_start_unit"},{"id":"T2","span":{"begin":212,"end":229},"obj":"age_range"},{"id":"T11","span":{"begin":212,"end":214},"obj":"age_start"},{"id":"T7","span":{"begin":200,"end":206},"obj":"age_category"}]}